All terms in GO

Label Id Description
5-aminolevulinic acid transmembrane transporter activity GO_0140485 [Enables the transfer of 5-aminolevulinic acid from one side of a membrane to the other.]
negative regulation of interleukin-15 production GO_0032698 [Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-15 production.]
interleukin-22 binding GO_0042017 [Binding to interleukin-22.]
5-aminolevulinic acid import across plasma membrane GO_0140484 [The directed movement of 5-aminolevulinic acid from outside of a cell, across the plasma membrane and into the cytosol.]
interleukin-20 receptor activity GO_0042016 [Combining with interleukin-20 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.]
obsolete negative regulation of interleukin-14 production GO_0032697 [OBSOLETE. Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-14 production.]
serine palmitoyltransferase complex GO_0017059 [A protein complex that catalyses the condensation of L-serine with palmitoyl-CoA to form 3-ketosphinganine, the sphingoid base which is the starting point for all sphingolipids. In bacteria the enzyme is a cytoplasmic homodimer, whereas in eukaryotes the enzyme is a multiprotein complex localised to the endoplasmic reticulum. The eukaryotic complex consists of catalytic components (SPTLC1, SPTLC2 and SPTLC3 in humans; LCB1 and LCB2 in S. cerevisiae) and regulatory components, which include activators (SPTSSA/SPTSSB in humans, TSC3 in S. cerevisiae) and negative regulators (ORMDL1/ORMDL2/ORMDL3 in humans, ORM1/2 in S. cerevisiae ).]
FH1 domain binding GO_0017058 [Binding to a FH1 domain of a protein, a proline-rich domain, usually located in front of a FH2 domain.]
6-phosphogluconolactonase activity GO_0017057 [Catalysis of the reaction: 6-O-phosphono-D-glucono-1,5-lactone + H2O = 6-phospho-D-gluconate + H+.]
structural constituent of nuclear pore GO_0017056 [The action of a molecule that contributes to the structural integrity of the nuclear pore complex, a protein-lined channel in the nuclear envelope that allows the transfer of macromolecules.]
negative regulation of RNA polymerase II transcription preinitiation complex assembly GO_0017055 [Any process that stops, prevents, or reduces the frequency, rate or extent of RNA polymerase II transcriptional preinitiation complex assembly.]
negative cofactor 2 complex GO_0017054 [A heterodimeric protein complex that can stably associate with TATA-binding protein on promoters, thereby preventing the assembly of transcription factors TFIIA and TFIIB and leading to repression of RNA polymerase II transcription. The two subunits, NC2alpha (Drap1) and NC2beta (Dr1), dimerize through histone fold domains of the H2A/H2B type present in the amino termini.]
negative regulation of interleukin-1 alpha production GO_0032690 [Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 alpha production.]
obsolete insulin-like growth factor binding protein GO_0017052 [OBSOLETE. (Was not defined before being made obsolete).]
S-methyl-5-thioadenosine phosphorylase activity GO_0017061 [Catalysis of the reaction: 5'-methylthioadenosine + phosphate = adenine + 5-methylthio-D-ribose 1-phosphate.]
3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity GO_0017060 [Catalysis of the reaction: GDP-L-fucose + beta-D-galactosyl-(1,3)-N-acetyl-D-glucosaminyl-R = GDP + beta-D-galactosyl-(1,3)-[alpha-L-fucosyl-(1,4)]-N-acetyl-D-glucosaminyl-R.]
interleukin-20 binding GO_0042015 [Binding to interleukin-20.]
negative regulation of interleukin-16 production GO_0032699 [Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-16 production.]
interleukin-19 receptor activity GO_0042014 [Combining with interleukin-19 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.]
interleukin-19 binding GO_0042013 [Binding to interleukin-19.]